+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term results of pediatric liver transplantation: an analysis of 569 transplants



Long-term results of pediatric liver transplantation: an analysis of 569 transplants



Annals of Surgery 228(3): 411-420



To analyze a single center's 13-year experience with 569 pediatric orthotopic liver transplants for end-stage liver disease. Despite advances in medical therapy, liver replacement continues to be the only definitive mode of therapy for children with end-stage liver disease. Innovative surgical techniques and improved immunosuppression have broadened the application of liver replacement for affected children. However, liver transplantation in the child remains challenging because of the scarcity of donor organs, complex surgical technical demands, and the necessity to prevent long-term complications. The medical records of 440 consecutive patients younger than 18 years of age undergoing orthotopic liver transplantation for end-stage liver disease from March 20, 1984, to November 15, 1997, were reviewed. Results were analyzed using Cox multivariate regression analysis to determine the statistical strength of independent associations between pretransplant covariates and patient and graft survival. Actuarial patient and graft survival rates were determined at 1, 3, 5, and 10 years. The type and incidence of posttransplant complications were determined, as was the quality of long-term allograft function. The median follow-up period was 4.1 years. Biliary atresia was the most common cause (50.4%) of endstage liver disease in this patient population. The median recipient age was 2.4 years; 239 patients (54%) were younger than 3 years of age and 1 11 patients (25%) were younger than 1 year of age. There were 471 whole organs, 29 were ex vivo reduced size, 33 were living-related donor, and 36 were in situ split-liver allografts. Three hundred forty-three (78%) patients underwent a single allograft, whereas 97 patients required retransplantation; hepatic artery thrombosis was the most common indication for retransplantation (55 patients). The 1-, 3-, 5-, and 10-year actuarial patient survival rates were 82%, 80%, 78%, and 76%, respectively; allograft survival rates were 68%, 63%, 60%, and 54%. Long-term liver function remains excellent: current median follow-up values for total bilirubin and aspartate aminotransferase were 0.5 mg/dl and 54 IU/L, respectively. Cox multivariate regression analysis demonstrated that pretransplant patient age, the era of transplantation, and the number of allografts performed significantly and independently predicted patient survival rates, whereas allograft type and pretransplant diagnosis did not. Liver transplantation in the pediatric patient is a durable procedure that provides excellent long-term survival. Although there have been overall improvements in patient outcome with increased experience, the effect is most pronounced for patients younger than 1 year of age. Retransplantation, although effective in a meaningful number of patients, continues to carry a progressive decrement in survival with the number of allografts performed. Use of living-related and in situ split-liver allografts has dramatically reduced waiting times for small children and has improved patient survival.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046572517

Download citation: RISBibTeXText

PMID: 9742924


Related references

Long-term results of living-related donor liver graft transplantation: a single-center analysis of 110 transplants. Transplantation 72(1): 95-99, 2001

Angioplasty treatment of hepatic vein stenosis in pediatric liver transplants: long-term results. Transplant International 18(5): 556-561, 2005

Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program. Cmaj 166(13): 1663-1671, 2002

Long-term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. American Journal of Transplantation 13(7): 1830-1839, 2013

Long-term results of renal transplantation: A single-center analysis of 1200 transplants. Transplantation Proceedings 38(2): 454-456, 2006

Long-term results in pediatric ABO-incompatible liver transplantation. Transplantation Proceedings 31(1-2): 467-468, 1999

Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation. Liver Transplantation 16(7): 847-855, 2010

Impact of donor-recipient sex match on long-term survival after heart transplantation in children: An analysis of 5797 pediatric heart transplants. Pediatric Transplantation 20(2): 249-255, 2016

Long-term results of the percutaneous transhepatic venoplasty of portal vein stenoses after pediatric liver transplantation. Pediatric Transplantation 15(5): 476-481, 2011

Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 69(12): 2573-2580, 2000

Midterm and long-term results of percutaneous endovascular treatment of venous outflow obstruction after pediatric liver transplantation. Journal of Vascular and Interventional Radiology 19(10): 1439-1448, 2008

Long-term graft outcome of pediatric liver transplantation in Copenhagen: analysis of the first 51 cases. Digestive Surgery 23(1-2): 65-73, 2006

Analysis of growth during prepubertal years in long-term survivors after pediatric orthotopic liver transplantation. Journal of Pediatric Endocrinology & Metabolism 17(9): 1221-1229, 2004

Long-term results with pediatric kidney transplants in adult recipients. Journal of the Formosan Medical Association 98(12): 807-813, 1999

Long-term results following kidney transplantation. An empirical analysis of 467 allogeneic kidney transplants concerning the effect of clinical and immunological variables on graft function. Medizinische Klinik 85(11): 637-642, 1990